Acuris coronavirus impact analysis
A special report by Acuris analysts and journalists examining the early impact of coronavirus on capital markets and sectors.
More on Industry
Alantra buys 40% stake in MCH Investment Strategies
Through this partnership, Alantra expects to expand its financial service offering and enlarge its investor base
How UK PE buyouts soared ahead of 2021 Budget
Amount of dealflow in the past three months is significantly higher than in previous December-February periods
Nordic players await distressed carve-out uptick
Carve-out activity in the Nordic region hit a three-year low last year, but was still propped up mainly by corporates divesting healthy assets
Biotech market provides dose of optimism
In the past year, the biotech market has seen buoyant activity, reaching record levels of investments
Latest News
Pride Capital sells stake in Kairos to trade
Direct lender invested in Kairos in 2018 and was part of Main Capital until its spin-out in 2019
One Equity Partners buys stake in Cicor Group
GP is to acquire a stake in the Switzerland-based circuit board producer from HEB Swiss Investment
Alantra buys 40% stake in MCH Investment Strategies
Through this partnership, Alantra expects to expand its financial service offering and enlarge its investor base
KKR invests $100m in Nordic Bioscience
GP is investing from Health Care Strategic Growth Fund, which held a final close in November 2017 on $1.2bn